ABT-072: Clinical Trials

5 trials of ABT-072, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow ABT-072: new trials by email Literature Review of ABT-072 trials Research Report on ABT-072

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults
ABT-072, Placebo - Hepatitis C
Phase 1CompletedAbbott242010-03-012010-10-25
Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072
ABT-072, Placebo - Hepatitis C
Phase 1CompletedAbbott522009-09-012010-10-21
Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compared to ABT-072 Capsule Formulation
ABT-072 - Hepatitis C
Phase 1CompletedAbbott182009-07-012010-10-21
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C
ABT-072, ketoconazole, Placebo - HCV Infection
Phase 1CompletedAbbott322009-04-012010-10-21
A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults
ABT-072, placebo - Hepatitis C
Phase 1CompletedAbbott1002008-09-012010-10-21

Conditions studied

Hepatitis C (5)

Sponsors

Abbott (5)

Countries

United States (4)  ·  Japan (1)

Top investigators

Daniel Cohen, MD (2)  ·  Daniel Cohen (1)  ·  Kazuko Kobayashi (1)